Project Grant HT9425261E160
Award Date 5/15/26
Completion Date 5/14/29
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- The Defense Health Agency (DHA) awarded the University of Washington a $543,285 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2028. This award supports research focused on transforming rhabdomyosarcoma treatment through the development and evaluation of new FDA-approved combination therapies. The project will be conducted at the University of Washington's Seattle, Washington location under the...
- Federal Grant Award Summary The University of Washington received a $1,494,943 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026 through March 31, 2029. The award supports research and development services focused on biomaterial strategies to improve the specificity and efficacy of Chimeric Antigen Receptor (CAR) T cell therapy for breast cancer treatment. This research initiative aligns...
- The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
- The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
- Federal Project Grant Award Summary The Washington University's Office of Sponsored Research Services received a $840,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2026, through May 31, 2028. The award supports research investigating hyperphosphorylation of tau serine 262 as a novel biomarker and therapy target in amyotrophic lateral sclerosis (ALS). This research initiative aligns with...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $1,508,132 to the University of Rhode Island Research Office through the Military Medical Research and Development program (CFDA 12.420) to conduct research on the use of bile acid-binding resins to decrease systemic per- and polyfluoroalkyl substance (PFAS) levels and improve serum lipid profiles in veterans. The four-year project, initiated on September 30, 2025 and scheduled for completion by September 29, 2029,...
- Federal Grant Award Summary The University of Washington received a $1.697 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project titled "Radiant Star Low-Volume Resuscitants for Burn Treatment in Austere Conditions." The award was effective May 1, 2026, with an ultimate completion date of April 30, 2029. Research will be conducted at the University of Washington's Seattle, Washington campus...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $834,915 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period May 1, 2026 through April 30, 2028. The project, titled "Development of Small Molecules to Disrupt TDP-43 Aggregation and Restore Function," will be conducted at the university's facilities in University City, Missouri. This award funds research and development activities...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...